
Mansour Oveissi
Examiner (ID: 18658, Phone: (571)270-3127 , Office: P/2415 )
| Most Active Art Unit | 2415 |
| Art Unit(s) | 2616, 2464, 2415, 2416 |
| Total Applications | 1005 |
| Issued Applications | 795 |
| Pending Applications | 89 |
| Abandoned Applications | 156 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18273670
[patent_doc_number] => 11612591
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-03-28
[patent_title] => Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea
[patent_app_type] => utility
[patent_app_number] => 17/735820
[patent_app_country] => US
[patent_app_date] => 2022-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25986
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17735820
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/735820 | Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea | May 2, 2022 | Issued |
Array
(
[id] => 17828248
[patent_doc_number] => 20220265552
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => ESLICARBAZEPINE SUSPENSION
[patent_app_type] => utility
[patent_app_number] => 17/734420
[patent_app_country] => US
[patent_app_date] => 2022-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17454
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17734420
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/734420 | ESLICARBAZEPINE SUSPENSION | May 1, 2022 | Pending |
Array
(
[id] => 19300119
[patent_doc_number] => 20240228688
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-11
[patent_title] => POLYMER AND COMPOSITION THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/288970
[patent_app_country] => US
[patent_app_date] => 2022-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16934
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18288970
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/288970 | POLYMER AND COMPOSITION THEREOF | Apr 28, 2022 | Pending |
Array
(
[id] => 19657025
[patent_doc_number] => 20240424090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-26
[patent_title] => COMPOSITIONS AND METHODS FOR USE IN IMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 18/287669
[patent_app_country] => US
[patent_app_date] => 2022-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15349
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18287669
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/287669 | COMPOSITIONS AND METHODS FOR USE IN IMMUNOTHERAPY | Apr 19, 2022 | Pending |
Array
(
[id] => 19657025
[patent_doc_number] => 20240424090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-26
[patent_title] => COMPOSITIONS AND METHODS FOR USE IN IMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 18/287669
[patent_app_country] => US
[patent_app_date] => 2022-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15349
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18287669
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/287669 | COMPOSITIONS AND METHODS FOR USE IN IMMUNOTHERAPY | Apr 19, 2022 | Pending |
Array
(
[id] => 18618549
[patent_doc_number] => 11751570
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-12
[patent_title] => Aluminosilicate glass with phosphorus and potassium
[patent_app_type] => utility
[patent_app_number] => 17/722688
[patent_app_country] => US
[patent_app_date] => 2022-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 17
[patent_no_of_words] => 20293
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17722688
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/722688 | Aluminosilicate glass with phosphorus and potassium | Apr 17, 2022 | Issued |
Array
(
[id] => 19316648
[patent_doc_number] => 20240238188
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-18
[patent_title] => OILY COSMETIC
[patent_app_type] => utility
[patent_app_number] => 18/289468
[patent_app_country] => US
[patent_app_date] => 2022-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7870
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 366
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18289468
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/289468 | OILY COSMETIC | Apr 13, 2022 | Pending |
Array
(
[id] => 17748012
[patent_doc_number] => 20220226215
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => PHOTOPROTECTIVE COMPOSITIONS COMPRISING A DIBENZOYLMETHANE DERIVATIVE, A MEROCYANINE COMPOUND AND A COMPOUND CAPABLE OF ACCEPTING THE TRIPLET EXCITED LEVEL ENERGY OF THE DIBENZOYLMETHANE COMPOUND
[patent_app_type] => utility
[patent_app_number] => 17/715355
[patent_app_country] => US
[patent_app_date] => 2022-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14536
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 212
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17715355
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/715355 | PHOTOPROTECTIVE COMPOSITIONS COMPRISING A DIBENZOYLMETHANE DERIVATIVE, A MEROCYANINE COMPOUND AND A COMPOUND CAPABLE OF ACCEPTING THE TRIPLET EXCITED LEVEL ENERGY OF THE DIBENZOYLMETHANE COMPOUND | Apr 6, 2022 | Abandoned |
Array
(
[id] => 17958836
[patent_doc_number] => 20220339416
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-27
[patent_title] => SILK FIBROIN-BASED MICRONEEDLES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/714025
[patent_app_country] => US
[patent_app_date] => 2022-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47043
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17714025
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/714025 | SILK FIBROIN-BASED MICRONEEDLES AND USES THEREOF | Apr 4, 2022 | Pending |
Array
(
[id] => 20315203
[patent_doc_number] => 12453742
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-28
[patent_title] => Bowel cleansing chemical composition and associated use therefore
[patent_app_type] => utility
[patent_app_number] => 17/655615
[patent_app_country] => US
[patent_app_date] => 2022-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 0
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17655615
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/655615 | Bowel cleansing chemical composition and associated use therefore | Mar 20, 2022 | Issued |
Array
(
[id] => 18642353
[patent_doc_number] => 11766406
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-26
[patent_title] => Soft gelatin capsules containing a mixture of analgesics and decongestants, expectorants, antitussives and/or antihistamines
[patent_app_type] => utility
[patent_app_number] => 17/692521
[patent_app_country] => US
[patent_app_date] => 2022-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5547
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 203
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17692521
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/692521 | Soft gelatin capsules containing a mixture of analgesics and decongestants, expectorants, antitussives and/or antihistamines | Mar 10, 2022 | Issued |
Array
(
[id] => 19158151
[patent_doc_number] => 20240150858
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-09
[patent_title] => USE OF MIXTURES COMPRISING GLYCEROL AND GLYCERIDES OF ORGANIC ACIDS IN AGRICULTURAL AND FORESTRY
[patent_app_type] => utility
[patent_app_number] => 18/280528
[patent_app_country] => US
[patent_app_date] => 2022-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11647
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18280528
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/280528 | USE OF MIXTURES COMPRISING GLYCEROL AND GLYCERIDES OF ORGANIC ACIDS IN AGRICULTURAL AND FORESTRY | Mar 7, 2022 | Pending |
Array
(
[id] => 17670801
[patent_doc_number] => 20220183968
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => SUSPENSION COMPONENT-SPECIFIC TRIAMCINOLONE AND MOXIFLOXACIN COMPOSITIONS AND ASSOCIATED METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/686373
[patent_app_country] => US
[patent_app_date] => 2022-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 70365
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -40
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17686373
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/686373 | Suspension component-specific triamcinolone and moxifloxacin compositions and associated methods of use | Mar 2, 2022 | Issued |
Array
(
[id] => 17858453
[patent_doc_number] => 11439591
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-13
[patent_title] => Moxifloxacin and triamcinolone compositions and associated methods
[patent_app_type] => utility
[patent_app_number] => 17/686368
[patent_app_country] => US
[patent_app_date] => 2022-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 70344
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17686368
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/686368 | Moxifloxacin and triamcinolone compositions and associated methods | Mar 2, 2022 | Issued |
Array
(
[id] => 17670800
[patent_doc_number] => 20220183967
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => LIMITED PARTICLE SIZE TRIAMCINOLONE AND MOXIFLOXACIN COMPOSITIONS AND ASSOCIATED METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/686371
[patent_app_country] => US
[patent_app_date] => 2022-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 70324
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -44
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17686371
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/686371 | Limited particle size triamcinolone and moxifloxacin compositions and associated methods of use | Mar 2, 2022 | Issued |
Array
(
[id] => 17640491
[patent_doc_number] => 20220168229
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-02
[patent_title] => BIODEGRADABLE EXTENDED RELEASE MICROSPHERE-HYDROGEL OCULAR DRUG DELIVERY SYSTEM AND METHOD
[patent_app_type] => utility
[patent_app_number] => 17/673504
[patent_app_country] => US
[patent_app_date] => 2022-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14709
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17673504
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/673504 | BIODEGRADABLE EXTENDED RELEASE MICROSPHERE-HYDROGEL OCULAR DRUG DELIVERY SYSTEM AND METHOD | Feb 15, 2022 | Pending |
Array
(
[id] => 17609709
[patent_doc_number] => 20220151988
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => Choline Esters
[patent_app_type] => utility
[patent_app_number] => 17/592700
[patent_app_country] => US
[patent_app_date] => 2022-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6402
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17592700
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/592700 | Choline Esters | Feb 3, 2022 | Abandoned |
Array
(
[id] => 17733401
[patent_doc_number] => 20220218860
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-14
[patent_title] => INDANE DERIVATIVES FOR MALODOR COUNTERACTION
[patent_app_type] => utility
[patent_app_number] => 17/591250
[patent_app_country] => US
[patent_app_date] => 2022-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9515
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17591250
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/591250 | INDANE DERIVATIVES FOR MALODOR COUNTERACTION | Feb 1, 2022 | Abandoned |
Array
(
[id] => 18994662
[patent_doc_number] => 11911479
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-27
[patent_title] => Vaginal hydrogel
[patent_app_type] => utility
[patent_app_number] => 17/590213
[patent_app_country] => US
[patent_app_date] => 2022-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2917
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17590213
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/590213 | Vaginal hydrogel | Jan 31, 2022 | Issued |
Array
(
[id] => 19608023
[patent_doc_number] => 12156882
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-03
[patent_title] => Anti-aging drug combination and use thereof
[patent_app_type] => utility
[patent_app_number] => 17/584997
[patent_app_country] => US
[patent_app_date] => 2022-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9149
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17584997
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/584997 | Anti-aging drug combination and use thereof | Jan 25, 2022 | Issued |